EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'

GLP-1 market leaders Eli Lilly and Company (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) faced a significant selloff on Thursday, as new weight-loss drugs from rival pharmaceutical companies began threatening the dominance of their flagship products, Zepbound and Wegovy.

Benzinga16:59 ET

Pfizer Options Spot-On: On July 18th, 266.35K Contracts Were Traded, With 2.96 Million Open Interest

On July 18th ET, $Pfizer(PFE.US)$ had active options trading, with a total trading volume of 266.35K options for the day, of which put options accounted for 30.65% of the total transactions, and

Moomoo News16:30 ET

COVID Activity Is Elevated Across 26 States In Summer Surge, Biden Remains In Isolation: 3 Vaccine Stocks To Watch

More than half of the states in the U.S. are experiencing significant Covid-19 activity in wastewater, and President Joe Biden remains in isolation after announcing Wednesday he caught the virus for

Benzinga15:59 ET

Valneava and Pfizer Nearing Lyme Vaccine Milestone

TipRanks15:17 ET

Pfizer/Valneva's Vaccine Study For Tick-Borne Infection Completes Primary Vaccination Series, Plans Approval In 2026

On Wednesday, Pfizer Inc (NYSE:PFE) and Valneva SE (NASDAQ:VALN) announced that the participants of the Phase 3 VALOR trial have completed the primary vaccination series (three doses) of Lyme disease vaccine candidate VLA15.

Benzinga14:05 ET

Express News | President Biden's Doctor Says President Biden's Vital Signs Remain Normal; He Will Continue To Conduct U.S. Business; Continues To Receive Paxlovid; Still Experiencing Mild Covid-19 Symptoms

Benzinga13:44 ET